第 1 到 11 筆結果,共 11 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2023 | Age-Dependent Effects of Acute Kidney Injury on End-Stage Kidney Disease and Mortality in Patients with Moderate to Severe Chronic Kidney Disease | YU-HSIANG CHOU ; TAI-SHUAN LAI ; YI-CHIH LIN ; WEN-CHIH CHIANG ; TZONG-SHINN CHU ; SHUEI-LIONG LIN ; YUNG-MING CHEN | Nephron | 2 | 2 | |
2 | 2021 | Angiopoietin-2 is associated with metabolic syndrome in chronic kidney disease | FAN-CHI CHANG ; Ming-Ching Lee; CHIH-KANG CHIANG ; Liu, Jia-Sin; TAI-SHUAN LAI ; WEN-CHIH CHIANG ; YUNG-MING CHEN ; TZONG-SHINN CHU | Journal of the Formosan Medical Association = Taiwan yi zhi | 5 | 4 | |
3 | 2020 | Effects and Safety of Statin and Ezetimibe Combination Therapy in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis | YI-CHIH LIN ; TAI-SHUAN LAI ; Wu H.-Y.; YU-HSIANG CHOU ; WEN-CHIH CHIANG ; SHUEI-LIONG LIN ; YUNG-MING CHEN ; TZONG-SHINN CHU ; YU-KANG TU | Clinical Pharmacology and Therapeutics | 10 | 10 | |
4 | 2019 | Emergency department utilization and resuscitation rate among patients receiving maintenance hemodialysis | YI-CHIH LIN ; Hsu H.-K.; TAI-SHUAN LAI ; WEN-CHIH CHIANG ; SHUEI-LIONG LIN ; YUNG-MING CHEN ; Chen C.-C.; TZONG-SHINN CHU | Journal of the Formosan Medical Association | 7 | 5 | |
5 | 2019 | The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy | Chi J.N.; TAI-SHUAN LAI ; Wu C.F.; Fu T.Y.; YU-HSIANG CHOU ; Chiu Y.L.; WEI-CHOU LIN ; WEN-CHIH CHIANG ; YUNG-MING CHEN ; MING-SHIOU WU | Journal of the Formosan Medical Association | 10 | 9 | |
6 | 2017 | Early initiation of immunosuppressive treatment in membranous nephropathy patients | CHIEH-KAI CHAN ; TAI-SHUAN LAI ; PING-MIN CHEN ; YU-HSIANG CHOU ; Wu C.F.; Chiu Y.L.; WEN-CHIH CHIANG ; YUNG-MING CHEN ; TZONG-SHINN CHU ; KWAN-DUN WU | Journal of the Formosan Medical Association | 5 | 4 | |
7 | 2017 | Restricted Use of Erythropoiesis-Stimulating Agent is Safe and Associated with Deferred Dialysis Initiation in Stage 5 Chronic Kidney Disease | SZU-YU PAN ; WEN-CHIH CHIANG ; PING-MIN CHEN ; Liu, Heng-Hsiu; YU-HSIANG CHOU ; TAI-SHUAN LAI ; CHUN-FU LAI ; Chiu, Yen-Ling; WAN-YU LIN ; YUNG-MING CHEN ; TZONG-SHINN CHU ; SHUEI-LIONG LIN | Scientific reports | 6 | 6 | |
8 | 2016 | Pentoxifylline: Evidence strong enough for renoprotection? | TAI-SHUAN LAI ; WEN-CHIH CHIANG ; YUNG-MING CHEN | Journal of the Formosan Medical Association | 11 | 9 | |
9 | 2015 | Multidisciplinary care program for advanced chronic kidney disease: Reduces renal replacement and medical costs | PING-MIN CHEN ; TAI-SHUAN LAI ; Chen P.Y.; CHUN-FU LAI ; SHAO-YU YANG ; VIN-CENT WU ; CHIH-KANG CHIANG ; Huang J.W.; JENQ-WEN HUANG ; WEN-CHIH CHIANG ; SHUEI-LIONG LIN ; KUAN-YU HUNG ; YUNG-MING CHEN ; TZONG-SHINN CHU ; MING-SHIOU WU ; KWAN-DUN WU ; TUN-JUN TSAI | American Journal of Medicine | 78 | 73 | |
10 | 2015 | Reply to comment on "Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease" | PING-MIN CHEN ; TAI-SHUAN LAI ; Chen P.-Y.; WEN-CHIH CHIANG | Journal of the Formosan Medical Association | 1 | 1 | |
11 | 2014 | Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease | PING-MIN CHEN ; TAI-SHUAN LAI ; Chen P.-Y.; CHUN-FU LAI ; VIN-CENT WU ; WEN-CHIH CHIANG ; YUNG-MING CHEN ; KWAN-DUN WU ; TUN-JUN TSAI | Journal of the Formosan Medical Association | 25 | 25 |